Skip to main content
Terug
GRRMF logo

Gerresheimer AG

Datakwaliteit: 100%
GRRMF
OTC Healthcare Medical - Instruments & Supplies
€ 22,00
€ 0,00 (0,00%)
Marktkapitalisatie: 759,88M
Dagbereik
€ 22,00 € 22,00
52-Weeksbereik
€ 19,17 € 83,00
Volume
200
50D / 200D Gem.
€ 40,52 / € 49,15
Vorige Slotkoers
€ 22,00

Quick Summary

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (631 peers)

Metriek Aandeel Sector Mediaan
P/E 6,9 0,2
P/B 0,5 3,0
ROE % 7,4 3,6
Net Margin % 5,4 3,8
Rev Growth 5Y % 9,5 9,9
D/E 0,9 0,2

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 4,58
€ 4,43 – € 4,71
2,73B 3
FY2029 € 4,75
€ 4,59 – € 4,89
2,70B 3
FY2028 € 4,12
€ 3,98 – € 4,24
2,58B 4

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-25 -€ 0,07 -€ 0,07 0,0%
2025-07-10 € 0,92 € 0,56 -38,9%
2025-04-09 € 0,39 -€ 0,54 -240,5%
2024-11-30 N/A € 1,14
2024-10-10 € 1,18 € 1,15 -2,5%
2024-07-11 € 1,24 € 1,24 0,0%
2024-04-11 € 0,64 € 0,65 +1,6%
2023-11-30 N/A € 1,31

Dividend History

7 yr streak

Yield

0,02%

Payout Ratio

0,39%

Growth (3Y)

-67,51%

Growth (5Y)

-49,17%

Ex-Date Payment Date Amount Yield
Jun 09, 2025 Jun 10, 2025 € 0,05 0,06%
Jun 07, 2024 Jun 10, 2024 € 1,35 1,27%
Jun 08, 2023 Jun 12, 2023 € 1,35 1,30%
Jun 09, 2022 Jun 13, 2022 € 1,33 1,57%
Jun 10, 2021 Jun 14, 2021 € 1,52 1,14%
Jun 25, 2020 Jun 29, 2020 € 1,35 1,52%
Jun 07, 2019 Jun 12, 2019 € 1,30 1,51%
Apr 26, 2018 Apr 30, 2018 € 1,33 1,34%
Apr 27, 2017 May 02, 2017 € 1,14 1,36%
Apr 29, 2016 Apr 29, 2016 € 0,97 1,10%
May 04, 2015 May 04, 2015 € 0,84 1,32%
May 02, 2014 May 02, 2014 € 0,97 1,06%
Apr 19, 2013 Apr 19, 2013 € 0,85 1,27%
Apr 27, 2012 Apr 27, 2012 € 0,79 1,29%
Apr 15, 2011 Apr 15, 2011 € 0,72 1,23%
Apr 30, 2009 Apr 30, 2009 € 0,53 2,53%
May 26, 2008 May 26, 2008 € 0,63 2,84%

Belangrijkste Punten

Revenue grew 9,45% annually over 5 years — modest growth
Negative free cash flow of -129,51M
P/E of 6,93 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,17%

Groei

Revenue Growth (5Y)
9,45%
Revenue (1Y)2,28%
Earnings (1Y)-5,52%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
7,42%
ROIC5,30%
Net Margin5,39%
Op. Margin9,70%

Veiligheid

Debt / Equity
0,85
Current Ratio1,01
Interest Coverage3,26

Waardering

P/E Ratio
6,93
Forward P/E9,07
P/B Ratio0,50
EV/EBITDA9,40
Dividend Yield0,02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 2,28% Revenue Growth (3Y) 5,85%
Earnings Growth (1Y) -5,52% Earnings Growth (3Y) 6,84%
Revenue Growth (5Y) 9,45% Earnings Growth (5Y) 5,50%
Profitability
Revenue (TTM) 2,04B Net Income (TTM) 109,72M
ROE 7,42% ROA 2,88%
Gross Margin 29,85% Operating Margin 9,70%
Net Margin 5,39% Free Cash Flow (TTM) -129,51M
ROIC 5,30% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,85 Current Ratio 1,01
Interest Coverage 3,26
Dividends
Dividend Yield 0,02% Payout Ratio 0,39%
Dividend Growth (3Y) -67,51% Dividend Growth (5Y) -49,17%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 6,93 Forward P/E 9,07
P/B Ratio 0,50 P/S Ratio 0,37
PEG Ratio -2,70 Forward PEG N/A
EV/EBITDA 9,40 Fwd EV/EBITDA 4,01
Forward P/S 0,33 Fwd Earnings Yield 11,03%
FCF Yield -17,04%
Market Cap 759,88M Enterprise Value 1,86B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 2,04B 1,99B 1,82B 1,50B 1,42B
Net Income 109,72M 116,13M 96,12M 83,79M 88,56M
EPS (Diluted) 3,18 3,48 3,06 2,67 2,82
Gross Profit 607,77M 597,31M 546,81M 442,23M 437,61M
Operating Income 197,47M 213,39M 169,31M 147,44M 156,46M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 3,81B 3,43B 3,35B 2,88B 2,62B
Total Liabilities 2,27B 1,96B 2,08B 1,88B 1,72B
Shareholders' Equity 1,51B 1,45B 1,24B 981,32M 883,83M
Total Debt 1,28B 1,04B 1,22B 1,13B 1,05B
Cash & Equivalents 186,38M 122,34M 112,79M 114,05M 87,95M
Current Assets 992,30M 849,57M 810,14M 657,18M 551,37M
Current Liabilities 985,50M 957,97M 1,10B 885,78M 579,46M